304 related articles for article (PubMed ID: 11361092)
1. Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts.
Kitzmann M; Fernandez A
Cell Mol Life Sci; 2001 Apr; 58(4):571-9. PubMed ID: 11361092
[TBL] [Abstract][Full Text] [Related]
2. [Interactions of proliferation and differentiation signaling pathways in myogenesis].
Milewska M; Grabiec K; Grzelkowska-Kowalczyk K
Postepy Hig Med Dosw (Online); 2014 May; 68():516-26. PubMed ID: 24864103
[TBL] [Abstract][Full Text] [Related]
3. Modulation of acto-myosin contractility in skeletal muscle myoblasts uncouples growth arrest from differentiation.
Dhawan J; Helfman DM
J Cell Sci; 2004 Aug; 117(Pt 17):3735-48. PubMed ID: 15252113
[TBL] [Abstract][Full Text] [Related]
4. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.
Halevy O; Novitch BG; Spicer DB; Skapek SX; Rhee J; Hannon GJ; Beach D; Lassar AB
Science; 1995 Feb; 267(5200):1018-21. PubMed ID: 7863327
[TBL] [Abstract][Full Text] [Related]
5. p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts.
Reynaud EG; Pelpel K; Guillier M; Leibovitch MP; Leibovitch SA
Mol Cell Biol; 1999 Nov; 19(11):7621-9. PubMed ID: 10523650
[TBL] [Abstract][Full Text] [Related]
6. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression.
Langley B; Thomas M; Bishop A; Sharma M; Gilmour S; Kambadur R
J Biol Chem; 2002 Dec; 277(51):49831-40. PubMed ID: 12244043
[TBL] [Abstract][Full Text] [Related]
7. [New insight into MyoD regulation: involvement in rhabdomyosarcoma pathway?].
Tintignac LA; Leibovitch MP; Leibovitch SA
Bull Cancer; 2001 Jun; 88(6):545-8. PubMed ID: 11459700
[TBL] [Abstract][Full Text] [Related]
8. Antagonistic regulation of p57kip2 by Hes/Hey downstream of Notch signaling and muscle regulatory factors regulates skeletal muscle growth arrest.
Zalc A; Hayashi S; Auradé F; Bröhl D; Chang T; Mademtzoglou D; Mourikis P; Yao Z; Cao Y; Birchmeier C; Relaix F
Development; 2014 Jul; 141(14):2780-90. PubMed ID: 25005473
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization.
Langen RC; Van Der Velden JL; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
FASEB J; 2004 Feb; 18(2):227-37. PubMed ID: 14769817
[TBL] [Abstract][Full Text] [Related]
10. Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation.
Cenciarelli C; De Santa F; Puri PL; Mattei E; Ricci L; Bucci F; Felsani A; Caruso M
Mol Cell Biol; 1999 Jul; 19(7):5203-17. PubMed ID: 10373569
[TBL] [Abstract][Full Text] [Related]
11. v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levels.
Falcone G; Ciuffini L; Gauzzi MC; Provenzano C; Strano S; Gallo R; Castellani L; Alemà S
Oncogene; 2003 Nov; 22(51):8302-15. PubMed ID: 14614454
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin.
Joulia D; Bernardi H; Garandel V; Rabenoelina F; Vernus B; Cabello G
Exp Cell Res; 2003 Jun; 286(2):263-75. PubMed ID: 12749855
[TBL] [Abstract][Full Text] [Related]
13. Regulation of MyoD function in the dividing myoblast.
Wei Q; Paterson BM
FEBS Lett; 2001 Feb; 490(3):171-8. PubMed ID: 11223032
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase.
Skapek SX; Rhee J; Spicer DB; Lassar AB
Science; 1995 Feb; 267(5200):1022-4. PubMed ID: 7863328
[TBL] [Abstract][Full Text] [Related]
15. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
Valdez MR; Richardson JA; Klein WH; Olson EN
Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
[TBL] [Abstract][Full Text] [Related]
16. MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions.
Ishibashi J; Perry RL; Asakura A; Rudnicki MA
J Cell Biol; 2005 Nov; 171(3):471-82. PubMed ID: 16275751
[TBL] [Abstract][Full Text] [Related]
17. MyoD induces the expression of p57Kip2 in cells lacking p21Cip1/Waf1: overlapping and distinct functions of the two cdk inhibitors.
Figliola R; Maione R
J Cell Physiol; 2004 Sep; 200(3):468-75. PubMed ID: 15254975
[TBL] [Abstract][Full Text] [Related]
18. MyoD induces apoptosis in the absence of RB function through a p21(WAF1)-dependent re-localization of cyclin/cdk complexes to the nucleus.
Peschiaroli A; Figliola R; Coltella L; Strom A; Valentini A; D'Agnano I; Maione R
Oncogene; 2002 Nov; 21(53):8114-27. PubMed ID: 12444547
[TBL] [Abstract][Full Text] [Related]
19. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D3 promotes myogenic differentiation and Pax7 transcription.
Gurung R; Parnaik VK
J Cell Biochem; 2012 Jan; 113(1):209-19. PubMed ID: 21898542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
